We’re beginning to see how mergers and acquisitions in the hospital industry are being impacted by President Biden’s executive order promoting competition in the American economy. The Federal Trade Commission recently announced policy changes, and the Department of Justice has been asked to consider policy changes, that boards of directors and C-suite officers must take into account when weighing transactions.
On this episode of Diagnosing Health Care, special guest Dr. Subramaniam (Subbu) Ramanarayanan, Managing Director at NERA Economic Consulting, and Epstein Becker Green attorneys John Steren, Patricia Wagner, and Dan Fahey discuss what leaders need to know about the government’s heightened antitrust scrutiny in the hospital market.
About the Diagnosing Health Care Podcast
The Diagnosing Health Care podcast series examines the business opportunities and solutions that exist despite the high-stakes legal, policy, and regulatory issues that the health care industry faces.
Trouble listening to this podcast? Please contact Kelli Sakalousky at firstname.lastname@example.org and mention whether you were at home or working within a corporate network. We’d also love to hear your suggestions for future episode topics.
Spread the Word
Would your colleagues, professional network, or friends benefit from Diagnosing Health Care? Please share the edition each week on LinkedIn, Facebook, YouTube, Instagram, and Twitter, and your connections can subscribe for email notifications.